Publication | Open Access
An open‐label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low‐grade non‐Hodgkin lymphoma
11
Citations
37
References
2005
Year
In this study, PMR was active and well-tolerated in patients with low-grade NHL, and the combination is deserving of further study.
| Year | Citations | |
|---|---|---|
Page 1
Page 1